Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ) has provided an announcement.
Shanghai Junshi Biosciences Co., Ltd. has announced a placement of new H shares under a general mandate, appointing a sole placing agent to facilitate the process. The placement involves issuing 41 million shares at HK$25.35 each, raising approximately HK$1,026 million in net proceeds. This strategic move is expected to enhance the company’s capital base and potentially strengthen its market position.
The most recent analyst rating on (HK:1877) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on Shanghai Junshi Biosciences Co., Ltd. Class H stock, see the HK:1877 Stock Forecast page.
More about Shanghai Junshi Biosciences Co., Ltd. Class H
Shanghai Junshi Biosciences Co., Ltd. is a joint stock company incorporated in China, operating in the biosciences sector. The company is focused on the development, production, and marketing of innovative therapeutic products, primarily targeting the healthcare market.
Average Trading Volume: 4,563,912
Technical Sentiment Signal: Buy
Current Market Cap: HK$36.34B
For an in-depth examination of 1877 stock, go to TipRanks’ Overview page.